Andreas Diacon, P., Sachiko Miyahara, P., Rodney Dawson, P., Xin Sun, P., Hogg, E., Kathleen Donahue, M., . . . William Bishai, P. (2020). Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: A phase 2a, open-label, randomised controlled trial. The Lancet Microbe, 1(2), e84. https://doi.org/10.1016/S2666-5247(20)30011-2

Andreas Diacon, ProfPhD, et al. "Assessing Whether Isoniazid Is Essential During the First 14 Days of Tuberculosis Therapy: A Phase 2a, Open-label, Randomised Controlled Trial." The Lancet Microbe 1, no. 2 (2020): e84. https://doi.org/10.1016/S2666-5247(20)30011-2.

Andreas Diacon, ProfPhD, et al. "Assessing Whether Isoniazid Is Essential During the First 14 Days of Tuberculosis Therapy: A Phase 2a, Open-label, Randomised Controlled Trial." The Lancet Microbe, vol. 1, no. 2, 2020, p. e84, https://doi.org/10.1016/S2666-5247(20)30011-2.